EN FR

news

03/04/2017

HRA Pharma appoints David Wright as Chief Executive Officer
14/03/2017

HRA Pharma Strengthens Board with Experienced Industry Experts
12/07/2016

HRA Pharma Announces CEO Transition to Position Company for the Next Phase of Growth
08/03/2016

A frisky continent: European women’s attitudes to sex and emergency contraception revealed!
19/02/2016

HRA Pharma Wraps up Landmark 2015 and Announces Investment by Astorg and its co-investor Goldman Sachs Merchant Banking Division to Support Ambitious ...

Media

filter by theme

< 1 2 3 4 5 6 7 8 9 10 >

June 2009

NorLevo®, HRA Pharma's Emergency Contraceptive Pill, Now Available in Canada.

May 2009

HRA Pharma Granted European Marketing Authorization for ellaOne®.

May 2009

HRA Pharma and Preglem Announce Successful Completion of Phase IIB for Ulipristal Acetate for the Treatment of Uterine Fibroids.

April 2009

HRA Pharma Appoints Erin Gainer as CEO to Lead Company Through Next Phases of International Growth.

April 2009

HRA Pharma and Nycomed Reinforce Partnership with Marketing and Distribution Agreement for ellaOne®

March 2009

HRA Pharma Receives CHMP Positive Opinion for ellaOne®

Février 2009

HRA Pharma and Gedeon Richter Enter into Marketing and Distribution Agreement

December 2008

HRA Pharma Strengthens European Operations with German Affiliate.